Skip to main content
   
    2000    
 
 
    2019
Billions of Chained 2009 U.S. Dollars
Name 2019 Preceding
Period
Year Ago
from Period
Health
2,091.50 2,190.46 2,190.46
Health services
1,948.38 2,049.26 2,049.26
Medical services by disease
1,671.72 1,771.88 1,771.88
Infectious and parasitic diseases
35.24 35.63 35.63
Neoplasms
114.84 94.43 94.43
Endocrine; nutritional; and metabolic diseases and immunity disorders
142.15 151.82 151.82
Mental illness
127.42 123.64 123.64
Diseases of the nervous system and sense organs
150.15 141.13 141.13
Diseases of the circulatory system
216.67 256.32 256.32
Diseases of the respiratory system
115.58 123.70 123.70
Diseases of the digestive system
114.87 113.93 113.93
Diseases of the genitourinary system
92.96 93.02 93.02
Complications of pregnancy; childbirth; and the puerperium
60.42 59.41 59.41
Diseases of the skin and subcutaneous organs
37.05 38.95 38.95
Diseases of the musculoskeletal system and connective tissue
214.92 222.15 222.15
Injury and poisoning
101.04 106.17 106.17
Symptoms; signs; and ill-defined conditions
121.85 164.07 164.07
Other
50.00 43.79 43.79
Diseases of the blood and blood-forming organs
18.86 17.65 17.65
Congenital anomalies
0.00 0.00 0.00
Certain conditions originating in the perinatal period
15.06 14.53 14.53
Residual codes; unclassified; all E codes
32.53 26.92 26.92
Medical services by provider
283.14 280.53 280.53
Dental services
117.53 115.15 115.15
Nursing homes
165.43 165.22 165.22
Proprietary and government nursing homes
113.65 112.87 112.87
Nonprofit nursing homes services to households
51.78 52.36 52.36
Medical products, appliances and equipment
151.20 145.95 145.95
Pharmaceutical and other medical products
82.58 79.30 79.30
Pharmaceutical products (without prescription drugs)
76.23 73.15 73.15
Nonprescription drugs
76.23 73.15 73.15
Other medical products
6.34 6.15 6.15
Therapeutic appliances and equipment
68.71 66.71 66.71
Corrective eyeglasses and contact lenses
36.21 35.19 35.19
Therapeutic medical equipment
32.61 31.62 31.62
   

Subscribe to the FRED newsletter


Follow us

Back to Top